Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PAVmed Inc.PAVM · Entity 7317 | Director | April 02, 2026 | April 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PAVmed Inc.
Report date April 02, 2026 · Filed April 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 21,653 |
Reported balance
After 2026-04-02 transaction · row 1
1 source rowRow 1 · 2026-04-02 · Grant · Acquired 13,930 · Balance 21,653 F1: Represents restricted stock granted to the reporting person under the issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock granted to the reporting person under the issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 02, 2026 Filed Apr 3, 2026 20:50 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantCommon stock | 13,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-26-000155 · form4.xml · nonDerivative · entry 1 Glennon Michael J · CIK 0001665434 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,653 F1 · shares: Represents restricted stock granted to the reporting person under the issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. F1 · price: Represents restricted stock granted to the reporting person under the issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:18 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantCommon stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-25-000043 · form4.xml · nonDerivative · entry 1 Glennon Michael J · CIK 0001665434 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,667 F1 · shares: Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. F1 · price: Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:41 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantCommon stock | 65,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-24-004279 · form4.xml · nonDerivative · entry 1 Glennon Michael J · CIK 0001665434 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,000 F1 · price: The issuer granted 65,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan. Read SEC document |
| January 30, 2023 Filed Feb 3, 2023 01:44 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee stock option (right to buy) · Derivative | 450,000 | $0.00 Strike: $0.48 | $0.00 |
DisclosureSEC source: 0001062993-23-002042 · form4.xml · derivative · entry 1 Glennon Michael J · CIK 0001665434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common stock · 450,000 shares Expires 2033-01-30 F1 · derivative.exercise_date: One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023. Read SEC document |
| December 07, 2022 Filed Dec 7, 2022 23:56 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 100,000 | $0.62 | $62,320.00 |
DisclosureSEC source: 0001062993-22-023503 · form4.xml · nonDerivative · entry 3 Glennon Michael J · CIK 0001665434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.6122 to $0.6382 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 06, 2022 Filed Dec 7, 2022 23:56 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 88,000 | $0.64 | $56,082.40 |
DisclosureSEC source: 0001062993-22-023503 · form4.xml · nonDerivative · entry 2 Glennon Michael J · CIK 0001665434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.5930 to $0.6746 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 05, 2022 Filed Dec 7, 2022 23:56 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon stock | 62,000 | $0.69 | $42,606.40 |
DisclosureSEC source: 0001062993-22-023503 · form4.xml · nonDerivative · entry 1 Glennon Michael J · CIK 0001665434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.67 to $0.6984 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 18, 2022 Filed Feb 24, 2022 01:25 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee stock option (right to buy) · Derivative | 80,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001062993-22-005493 · form4.xml · derivative · entry 1 Glennon Michael J · CIK 0001665434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common stock · 80,000 shares Expires 2032-02-18 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:27 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.44 | $0.00 |
DisclosureSEC source: 0001094891-21-000174 · edgar.xml · derivative · entry 1 Glennon Michael J · CIK 0001665434 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-04-01 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on September 30, 2021. Read SEC document |
| April 30, 2020 Filed May 4, 2020 22:03 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001094891-20-000076 · edgar.xml · derivative · entry 1 Glennon Michael J · CIK 0001665434 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-04-30 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on June 30, 2020. Read SEC document |
| March 07, 2019 Filed Mar 12, 2019 01:23 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001094891-19-000087 · edgar.xml · derivative · entry 1 Glennon Michael J · CIK 0001665434 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-03-07 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on March 31, 2019. Read SEC document |
| June 26, 2018 Filed Jul 11, 2018 21:49 UTC | PAVmed Inc. PAVM · Entity 7317 | OtherSeries Z Warrants · Derivative | 322,673 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001094891-18-000154 · edgar.xml · derivative · entry 2 Glennon Michael J · CIK 0001665434 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 0 Underlying: Common Stock · 322,673 shares Expires 2024-04-30 F2 · kind: Contribution to Pavilion Venture Partners LLC, of which the trust is a non-managing member. Read SEC document |
| June 26, 2018 Filed Jul 11, 2018 21:49 UTC | PAVmed Inc. PAVM · Entity 7317 | OtherSeries Z Warrants · Derivative | 322,673 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001094891-18-000154 · edgar.xml · derivative · entry 1 Glennon Michael J · CIK 0001665434 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 322,673 Underlying: Common Stock · 322,673 shares Expires 2024-04-30 F1 · kind: Pro rata distribution from HCFP/Capital Partners III LLC, of which the trust is a non-managing member. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 21:26 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001094891-18-000049 · edgar.xml · derivative · entry 1 Glennon Michael J · CIK 0001665434 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-02-14 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on March 31, 2018. Read SEC document |
| December 21, 2017 Filed Dec 29, 2017 15:04 UTC | PAVmed Inc. PAVM · Entity 7317 | OtherCommon Stock | 645,346 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-17-000290 · edgar.xml · nonDerivative · entry 2 Glennon Michael J · CIK 0001665434 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 0 F2 · kind: Contribution to Pavilion Venture Partners LLC, of which the trust is a non-managing member. Read SEC document |
| December 21, 2017 Filed Dec 29, 2017 15:04 UTC | PAVmed Inc. PAVM · Entity 7317 | OtherCommon Stock | 645,346 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-17-000290 · edgar.xml · nonDerivative · entry 1 Glennon Michael J · CIK 0001665434 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 645,346 F1 · kind: Pro rata distribution from HCFP/Capital Partners III LLC, of which the trust is a non-managing member. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.